"Le Centre Hospitalier de Tourcoing est un établissement public de santé. Il est membre du Groupement Hospitalier Territorial Lille Métropole Flandre Intérieure. L'hôpital comptabilise près de 155 000 consultations et possède 971 lits, dont 463 lits dédiés à la Médecine, Chirurgie et Obstétrique, localisés au niveau de l'hôpital Guy Chatiliez. Prenez contact."

During the past decade, CH Tourcoing conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 10 clinical trials were completed, i.e. on average, 18.5% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 3 clinical trials were completed. i.e. 9.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Tourcoing" #1 sponsor was "University Hospital, Lille" with 15 trials, followed by "Tourcoing Hospital" with 11 trials sponsored, "ANRS, Emerging Infectious Diseases" with 9 trials sponsored, "Gilead Sciences" with 8 trials sponsored and "Bristol-Myers Squibb" with 8 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Tourcoing" #1 collaborator was "Ministry of Health, France" with 6 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Région Nord-Pas de Calais, France" with 3 trials as a collaborator, "ViiV Healthcare" with 2 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "CH Tourcoing" are "HIV Infections" (13 trials), "HIV" (7 trials), "HIV-1 Infection" (6 trials), "Covid19" (5 trials) and "COVID-19" (4 trials). Many other conditions were trialed in "CH Tourcoing" in a lesser frequency.

Most popular intervention types in "CH Tourcoing" are "Drug" (41 trials), "Other" (25 trials), "Behavioral" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "FTC/TDF" (4 trials), "ATV" (3 trials), "Atazanavir" (3 trials) and "Questionnaire" (3 trials). Other intervention names were less common.

The vast majority of trials in "CH Tourcoing" are 80 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CH Tourcoing". 4 are not yet recruiting, 18 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in CH Tourcoing, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in CH Tourcoing, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 17 trials that are defined as “Not Applicable".